Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Alexion Japan Wants to Extend 2-Digit Growth, Ride on Reform Boon: Next Chief
Alexion aims to achieve double-digit annual growth in Japan by harnessing the tailwind of the FY2024 drug pricing reform, which embraced a series of positive changes for rare disease therapies, incoming country president Misako Hamamura says. Last month, Alexion Pharma,…
To read the full story
Related Article
- Misako Hamamura to Head Up Alexion Japan from Next Year
October 25, 2024
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





